Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(50.0%)
N/A
2(33.3%)
Phase 3
1(16.7%)
6Total
Phase 4(3)
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02214108Phase 3Completed

Effect of Physical Activity Through Interactive Video Games in Overweight Children

Role: lead

NCT01571856Phase 4Completed

Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants

Role: lead

NCT01577043Phase 4Completed

Efficacy of Racecadotril in Acute Watery Diarrhea in Children

Role: lead

NCT01564290Phase 4Completed

Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children

Role: lead

NCT00981877Not ApplicableCompleted

Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children

Role: lead

NCT00683982Not ApplicableCompleted

Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus

Role: lead

All 6 trials loaded